Intestinal calcium absorption assessed by a double-isotope method, decreased significantly with aging in 94 normal subjects (r = −0.22, P < 0.025). In 52 untreated patients with postmenopausal osteoporosis, calcium absorption was significantly lower than normal when either age or habitual calcium intake was used as a covariable (P < 0.001). Serum 25-hydroxyvitamin D (25-OH-D) and 1,25-dihydroxyvitamin D (1,25(OH) 2 D) were measured in 44 normal subjects and 27 osteoporotic patients. For all normals, calcium absorption and serum 1,25(OH) 2 D were positively correlated (r = 0.50, P < 0.001). In nonelderly normal subjects (ages 30-65 yr), dietary calcium intake correlated inversely with both calcium absorption (r = −0.39, P < 0.01) and with serum 1,25(OH) 2 D (r = −0.50, P < 0.01). Both osteoporotic patients and elderly normal subjects (ages 65-90 yr) differed from nonelderly normals in that these correlations were not present. In addition although serum 25-OH-D was normal, serum 1,25(OH) 2 D was significantly decreased in both osteoporotic patients and elderly normals (P < 0.001). In osteoporotic patients, calcium absorption increased significantly (P < 0.001) after 7 d administration of a small dose (0.4 µg/d) of synthetic 1,25(OH) 2 D 3 . In osteoporotics mean serum immunoreactive parathyroid hormone was either normal (COOH-terminal assay) or low (NH 2 -terminal assay) relative to age-matched controls, and mean serum phosphate was increased. 
A B S T R A C T Intestinal calcium absorption assessed by a double-isotope method, decreased significantly with aging in 94 normal subjects (r = -0.22, P < 0.025).
In 52 untreated patients with postmenopausal osteoporosis, calcium absorption was significantly lower than normal when either age or habitual calcium intake was used as a covariable (P < 0.001). Serum related (r = 0.50, P < 0.001). In nonelderly normal subjects (ages yr), dietary calcium intake correlated inversely with both calcium absorption (r = -0.39, P < 0.01) and with serum 1,25(OH)2D (r = -0.50, P < 0.01). Both osteoporotic patients and elderly normal subjects (ages 65-90 yr) differed from nonelderly normals in that these correlations were not present.
In addition although serum 25-OH-D was normal, serum 1,25(OH)2D was significantly decreased in both osteoporotic patients and elderly normals (P < 0.001).
In osteoporotic patients, calcium absorption increased significantly (P < 0.001) after 7 (10) . Although comparable data are not available in man, Boyle et al. (11) have shown in rats that the adaptive increase in intestinal calcium absorption in response to low calcium intake is mediated by increased production of 1,25(OH)2D.
In the present study, we have measured calcium absorption in normal and osteoporotic subjects and related it to serum levels of vitamin D metabolites. We wished to investigate the role of the vitamin D endocrine system in the pathogenesis of impaired calcium absorption in patients with postmenopausal osteoporosis. We also wished to determine whether changes in calcium absorption with aging and in response to differing levels of dietary calcium were related to changes in serum levels of vitamin D metabolites.
METHODS
Normal subjects and patients. 94 normal subjects (77 women and 17 men) whose ages ranged from 30 to 90 yr underwent calcium absorption studies. All normal subjects were volunteers. They were ambulatory, in good health, and not on any medical therapy of taking supplementary vitamins. They had no previous history of back pain, or fractures, and roentgenograms of the spinal column showed no evidence of vertebral fractures. All had normal values for serum calcium, phosphorus, alkaline phosphatase, and glutamic oxaloaceticacid-transaminase. Renal function as assessed by a 24-h urine creatinine clearance was appropriate for their respective age. 44 of them (41 women Tests were performed after subjects had been on their usual intake of calcium, phosphorus, and vitamin D. A diet history was obtained by a trained dietitian in 74 ofthe female subjects. To assess the reproducibility of the diet history, repeat measurements were obtained in 17 nonelderly subjects (12 normal and 5 osteoporotic), ages 21-62 yr, and in 10 elderly subjects (7 normal and 3 osteoporotic), ages 70-85 yr. Thev were performed by a second dietitian after an interval of6 mo-3 yr.
Laboratory studies. A double-isotope method was used to assess intestinal calcium absorption. The fraction of radiocalcium dose absorbed at the end of a 6-h test was calculated by computer with the use of a mathematical deconvolution method, as described (7) . All studies were initiated in the fasting state between 0800 and 0900 h. No food was allowed during the first 4 h of the study, at the end of which time a low calcium lunch was given.
A dose of 10 ,uCi ofhigh specific activity 47Ca (Atomic Energy Commission, Oak Ridge, Tenn.) was given orally with 100 mg of calcium carrier (as calcium chloride) in 200 ml of deionize(d water. 5 min after the oral calcium drink, 10 gCi of sterile, pyrogen-free 45Ca was injected intravenously. Heparinizedl blood samples were serially obtained on 10 occasions during the 6-h period of the test. 4 ml of plasma was counted for 47Ca in a standard well-type y-counter (1185 Searle Automatic, Searle Analytic Co., Des Plaines, Ill.) by using a single-channiel pulse-height analyzer to exclude counts from the daughter isotope, 47Sc. For determination of 45Ca radioactivity, 2 ml of plasma was placed in a scintillation solution (Instagel, Packard Instrument Co., Inc. Downers Grove, Ill.), and a-emissions were counted in a scintillation counter after waiting a minimumi of 8 wk for decay of 47Ca and 47Sc. All counts were correctedl for quenching and for 45Ca contamination of the oral 47Ca preparation.
Serum 25-hydroxyvitamin D (25-OH-D) was measuredI by a modification (12) of the radioassay described by Haddadl and Chyu (13) . The competitive binding assay used rachitic rat renal cytosol for binding. Preparation of the serum differed. Methanol-chlorofonn (2:1) was used for extraction of lipids (14) . This extract was chromatographed on a Sephadex LH-20 column (0.9 x 20 cm; Pharmacia Fine Chemicals Inc., Piscataway, N. J.) in chloroform-hexane (1:1), and the fractions containing both 25-OH-D2 and 25-OH-D3 were combined (15) .
Fractions containing 25-OH-D were evaporated to dryness under nitrogen and redissolved in 95% ethanol for assay. Competition for binding of labeled 25-OH-D3 by unlabeled 25-OH-D2 and 25-OH-D3 is equivalent in this assav systemii, thus enabling us to measure total 25-OH-D. The coefficient of interassay variation calculated for the current study was 9.6%. Serum 1,25(OH)2D was measured by the method of Eismiian et al. (16) in the laboratory of Dr. H. F. DeLuca (Madison, WVis.). 5 ml of plasma was placed in a separatory funnel, to which 900 cpm of [3H11,25(OH)2D3 (78 Ci/mmol) was added. A methylene chloride extract was chromatographed on a Sephadex LH-20 column (0.7 x 9 cm) in hexane-chloroform-methanol (9:1:1). Fractions containing 1,25(OH)2D were evaporated under nitrogen, redissolved in hexane, and then subjected to high-pressure liquid chromatography on a microporasil column (0.4 x 30 cm, Waters Associates, Inc., Milford, Mass.) run in 9:1 hexane-isopropanol at a flow rate of 2 ml/min and 700 lb/in2. The overall recovery during extraction and chromatography was 74+5.2% (SD). The fraction containing 1,25-(OH)2D was collected and measured by a competitive binding assay using a rachitic chick intestinal cytosol preparation.
[3H]1,25(OH)2D3, 3 17 normal subjects (after 7 d-6 mo) and in 14 osteoporotic subjects (after 1-6 mo).
RESULTS
In the 94 normal.subjects, fractional calcium absorption decreased with age (r = -0.22, P < 0.025). Individual values in 52 osteoporotics are shown in relationship to the 95% confidence limits about the normal regression of calcium absorption on age for normal subjects in Fig. 1 . The mean for osteoporotic subjects was significantly lower than normal (P < 0.001), analysis ofcovariance). In 74 normal subjects in whom diet histories were obtained, fractional calcium absorption was correlated inversely with the dietary calcium intake (r = -0.29, P < 0.05). When these subjects were divided into nonelderly (<65 yr) and elderly (>65 yr) groups, however, the correlation between fractional calcium absorption and dietary calcium intake was improved in the 54 subjects in the nonelderly group (r = -0.39, P < 0.02), whereas in the 20 elderly subjects there was no significant correlation (r = 0.03). Individual values for osteoporotic patients and elderly normal subjects are shown in relationship to the 95% confidence limits about the normal regression of calcium absorption on dietary calcium intake for nonelderly normal subjects in Fig. 2 . In 17 out of20 elderly normal subjects values for absorption on intake were below the mean line. The mean for the osteoporotic patients was significantly lower than normal (P < 0.001, analysis of covariance) and 15 of the 52 values were below the 95% confidence limits. In the osteoporotic patients, there was no correlation between intestinal calcium absorption and dietary calcium intake.
In the 44 normal subjects who had serum vitamin D metabolites measured, 34 were nonelderly (<65 yr) and 10 (Fig. 8) . Serum iPTH in the osteoporotic group was not significantly lower when assessed by the COOH-terminal assay but was significantly lower than normal (P < 0.02) when assessed by the NH2-terminal assay. Mean serum calcium was similar in the two groups, but mean serum phosphate was significantly higher in the osteoporotic group (P < 0.025). The correlation of serum 1,25(OH)2D with serum phosphate in the normal subjects was not significant (r = -0. phosphate in osteoporotic patients and all normal subjects were merged, however, there was a significant inverse correlation between serum phosphate and serum 1,24(OH)2D (r = -0.35, P < 0.01). In comparison, serum calcium in the normal subjects, the osteoporotic patients, or in the combined group showed no correlation with serum 1,25(OH)2D (r = 0.08).
Administration of 1,25(OH)2D3. For 31 subjects who had replicate calcium absorption studies made without intervening treatment, the mean ± SE change (A) in fractional absorption was -0.0012±0.01, which was not significantly different from zero. In 20 ofthe 24 osteoporotic patients who received 0.4 g,g/d, calcium absorption increased. For this group, the mean increase in fractional absorption of0. 12±0.02 was highly significant (P < 0.001). Three osteoporotic patients who failed to respond to the lower test dose were retested while taking 0.8 itg/d, and all three had increased fractional absorption with this larger dose. In the 13 normal subjects, the mean±SE increase in fractional calcium Aging, Osteoporosis, and Serum Vitamin D Metabolites absorption was 0.10±0.02 after the administration of 0.4 ,ug/d of 1,25(OH)2D3, and this was significant (P < 0.001). The mean increase in 24-h urinary calcium excretion on the 7th d was 63 mg/24 h in the osteoporotic subjects and 78 mg/24 h in the normals subjects; in both groups the increase in urinary calcium was significant (P < 0.01). Reproducibility of diet history. In the 27 subjects the correlation between the first and second diet history was 0.87. The percent difference between the two diet histories was 11% in the elderly groups and 15% in the younger group, indicating good reproducibility of the method.
DISCUSSION
Our finding that serum 1,25(OH)2D levels are positively correlated with fractional calcium absorption in normal humans is consistent with the belief that 1,25(OH)2D is an important physiologic regulator ofcalcium absorption. Although a correlation between absorption and serum 1,25(OH)2D has previously been reported in humans for merged data of normals and patients with idiopathic hypercalciuria and primary hyperparathyroidism (19), our study is the first demonstration of a significant correlation within the normal range. Also, it is the first demonstration in normal humans that serum 1,25(OH)2D correlates negatively with dietary calcium intake and, thus, probably is the mediator of intestinal adaptation to changes in dietary calcium intake.
In osteoporotic women, calcium absorption assessed by an accurate double-isotope technique was lower than normal when either age or dietary calcium intake was used as a covariable. The abnormality in absorption was greatest in those osteoporotic patients who had relatively low dietary calcium intakes, which suggests impaired intestinal adaptation. Although elderly nonosteoporotic subjects also had decreased calcium absorptipn and impaired adaptation to low dietary calcium intake, these abnormalities were more pronounced iq the osteoporotic patients. Serum Decreased production of 1,25(OH)2D could be caused either by a primary (intrinsic) defect of la-hydroxylation in the kidney or by a secondary decrease of one or more factors that normally stimulate this enzyme. In the first instance, serum PTH should be increased; in the second, it should be decreased. As we and others have previously reported (22) (23) (24) ,2 and as we show again here, serum iPTH is low or normal (22, 25) in most patients with osteoporosis. In two studies higher serum iPTH levels have been reported in some osteoporotic subjects (26, 27) and in a further study of a small but selected population, serum iPTH was elevated in 38% of their sixteen patients (28) . In our own combined series of 87 osteoporotics this subset with high serum iPTH represents only about 10% of the total (22, 24) and may represent etiologically a subgroup (29) . Thus, we believe that in the majority of osteoporotic subjects in this study, decreased conversion of 25-OH-D to 1,25(OH)2D is more likely to be a secondary rather than a primary event. The secondary factors that could decrease 25-OH-D lad-hydroxylase activity (9) and that were either observed or inferred to be present in our study are decreased mean serum PTH and increased mean serum phosphate levels. Also, there is indirect evidence in birds (30, 31) and in humans (32) that estrogen deficiency per se decreases 25-OH-D la-hydroxylase activity. The menopause would be an incomplete explanation however, because postmenopausal women both with and without osteoporosis are estrogendeficient. It has been suggested that when estrogen is deficient, bone resorbing cells have increased sensitivity to circulating endogenous PTH, whereas the kidney retains its normal sensitivity (22, 33, 34 (38) .
In summary, our studies are consistent with the hypothesis that increased bone loss in postmenopausal osteoporotic women may be the indirect cause of impaired calcium absorption. A possible sequence of events that could account for our findings are shown in Fig. 9 . In normal male and female subjects, calcium absorption continues to decrease into the 10th decade of life (1) (2) (3) , and the effect of aging on calcium absorption may be additive to the effects of the menopause. Also, there is evidence (summarized by Gallagher and Riggs [39] ) that the amount of dietarv calcium required to prevent negative calcium balance increases with age and is much higher than that consumed by most elderly persons. Both Ireland and Fordtran (40) , who studied calcium absorption with a triple-lumen jejunal perfusion system after 4 to 8 wk ofadaptation to first a 300 mg, and then a 2000 mg calcium diet, and ourselves in the present study found that elderly subjects had poor adaptation to lowver dietary calcium intakes. Thus, impaired intestinal calcium absorption and adaptation, especially at low calcium intakes, might contribute to age-related bone loss.
In the elderly subjects, the decreased serum 1, FIGURE 9 Model for pathogenesis of impaired calciumii absorption in postmenopausal osteoporosis, which is consistent with the data observed in this studv.
aging both in normal subjects (24, 41) 
